Good decisions require good information
Find hidden gems and smart strategies from top experts when you join Seeking Alpha.
XBIT XBiotech Inc.Stock Price & Overview
$7.24
XBIT Stock Price
Quant Ranking
XBIT Analysis
XBIT News
Latest Headlines
Ratings Summary
People Also Follow
Similar to XBIT
ETFs Holding XBIT
XBIT Company Profile
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBIT Revenue
XBIT Earnings Per Share
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
XBIT Ownership
XBIT Peers
Risk
Technicals
XBIT Transcripts
XBIT SEC Filings
Press Releases
XBIT Income Statement
XBIT Balance Sheet
XBIT Cash Flow Statement
XBIT Long Term Solvency
Discover More
You may be interested in: